Chemicals & plastics

The investment house predicts a sharp increase in second quarter revenue to a record level.

The company's share jumped 3.5% in morning trading on the TASE.

The investment bank reiterates "Buy" rating and target price for Israel Chemicals

Slowing organic growth does not bode well for the second quarter.

Israel Chemicals' current price level represents a 20% discount on analyst Amir Adar's target for the stock.

The investment bank's 12-month EPS target is 10% above the consensus.

"The merger with Carmel Olefins will give Oil Refineries a competitive edge."

Analyst Joseph Wolf feels it is still not too late to invest in the stock.

The firms talked in the past, but didn't reach official negotiations.

The power plant will cost $250 million.

"We view Israel Corp. as a play on fertilizers more than anything else."

Fidelity International Ltd. is no longer a party at interest in the company.

Israel Corp. VP Goldschmidt: We are not the dark forces.

Analysts even look for "better things to come" at Israel Chemicals.

It is on pace to become the Israeli company reporting the highest quarterly profit.

The target for Makhteshim-Agan is now NIS 40, and for Israel Chemicals NIS 81.